Search research articles
Contact Us
Filters
Showing results (21-30 of 251) with videos related to
Page
of 26
Sort By:
Annals of the New York Academy of Sciences
|
November 30, 1993
Optimizing combination chemotherapy for rheumatoid arthritis
D E Furst
Pharmacotherapy
|
September 1, 1983
Mechanism of action, pharmacology, clinical efficacy and side effects of auranofin. An orally administered organic gold compound for the treatment of rheumatoid arthritis
D E Furst
The Journal of Rheumatology. Supplement
|
October 1, 1988
Clinically important interactions of nonsteroidal antiinflammatory drugs with other medications
D E Furst
Agents and Actions. Supplements
|
January 1, 1985
Significance of NSAID serum to response relationships
D E Furst
Agents and Actions. Supplements
|
January 1, 1985
Synovial fluid kinetics of non-steroidal anti-inflammatory drugs
D E Furst
Bailliere'S Clinical Rheumatology
|
August 1, 1988
The basis for variability of response to anti-rheumatic drugs
D E Furst
Rheumatology (Oxford, England)
|
January 26, 2000
Leflunomide, mycophenolic acid and matrix metalloproteinase inhibitors
D E Furst
The Journal of Rheumatology. Supplement
|
October 20, 2001
The status of stem cell transplantation for rheumatoid arthritis: a rheumatologist's view
D E Furst
Journal Des Maladies Vasculaires
|
July 10, 1999
The endothelium in the pathogenesis of systemic sclerosis: is it primary or secondary?
D E Furst
British Journal of Rheumatology
|
November 1, 1995
Practical clinical pharmacology and drug interactions of low-dose methotrexate therapy in rheumatoid arthritis
D E Furst
Page
of 26
Search research articles
Search
Showing results (21-30 of 251) with videos related to
Sort By:
Page
of 26
Annals of the New York Academy of Sciences
|
November 30, 1993
Optimizing combination chemotherapy for rheumatoid arthritis
D E Furst
Pharmacotherapy
|
September 1, 1983
Mechanism of action, pharmacology, clinical efficacy and side effects of auranofin. An orally administered organic gold compound for the treatment of rheumatoid arthritis
D E Furst
The Journal of Rheumatology. Supplement
|
October 1, 1988
Clinically important interactions of nonsteroidal antiinflammatory drugs with other medications
D E Furst
Agents and Actions. Supplements
|
January 1, 1985
Significance of NSAID serum to response relationships
D E Furst
Agents and Actions. Supplements
|
January 1, 1985
Synovial fluid kinetics of non-steroidal anti-inflammatory drugs
D E Furst
Bailliere'S Clinical Rheumatology
|
August 1, 1988
The basis for variability of response to anti-rheumatic drugs
D E Furst
Rheumatology (Oxford, England)
|
January 26, 2000
Leflunomide, mycophenolic acid and matrix metalloproteinase inhibitors
D E Furst
The Journal of Rheumatology. Supplement
|
October 20, 2001
The status of stem cell transplantation for rheumatoid arthritis: a rheumatologist's view
D E Furst
Journal Des Maladies Vasculaires
|
July 10, 1999
The endothelium in the pathogenesis of systemic sclerosis: is it primary or secondary?
D E Furst
British Journal of Rheumatology
|
November 1, 1995
Practical clinical pharmacology and drug interactions of low-dose methotrexate therapy in rheumatoid arthritis
D E Furst
Page
of 26